Life sciences companies in the US increasingly face decisions about expanding or establishing manufacturing capacity. With maturing pipelines, advanced therapies, and ongoing reshoring efforts, many organizations look for external partners to navigate site selection and facility construction. These projects involve high costs, strict regulatory requirements, and complex timelines. Partnering with experienced firms can help manage the process more effectively.
In 2026, reshoring continues to gain momentum as companies bring manufacturing back to the United States. This shift creates both opportunities and challenges, from evaluating locations to ensuring facilities meet current good manufacturing practice standards. Here is a practical look at how to approach these partnerships.
Why Partnering Makes Sense
Building or expanding a manufacturing facility in biotech, pharma, or medtech requires expertise across engineering, regulatory affairs, supply chain logistics, and project management. Internal teams often lack the bandwidth or specialized experience for large scale capital projects. External partners bring proven methodologies, industry relationships, and the ability to anticipate common pitfalls.
Many life sciences firms now collaborate with specialized consultants, engineering procurement and construction management providers, or site selection experts. These partnerships allow companies to focus on their core science while leveraging outside knowledge for execution.
Key Steps in Selecting the Right Partner
Start by defining your project needs clearly. Determine the scale of the facility, the types of products it will support, timelines, and budget parameters. This clarity helps evaluate potential partners more effectively.
Look for firms with direct experience in life sciences manufacturing. Relevant track records in cell and gene therapy facilities, biologics production, or medical device manufacturing carry significant weight. Ask about past projects of similar scope and complexity, including any FDA or international regulatory interactions.
Evaluate their network and resources. Strong partners maintain relationships with economic development organizations, utility providers, contractors, and regulatory consultants. This network can accelerate site identification and permitting processes.
Consider the full range of services offered. Some firms specialize in site selection only, while others provide end to end support including design, construction oversight, validation, and start up. Choose based on your internal capabilities and project gaps.
Site Selection Considerations
Site selection forms a critical early phase. Partners can help assess factors such as workforce availability, utility infrastructure, logistics access, and state incentives. In reshoring efforts, companies often prioritize locations with established life sciences clusters or supportive policies in states like North Carolina, Texas, Indiana, and others outside traditional coastal hubs.
Experienced firms conduct thorough analyses of power reliability, water supply, transportation networks, and expansion potential. They also factor in community readiness and long-term operating costs. This data driven approach helps avoid sites that look attractive initially but create problems later.
Facility Design and Construction Phase
Once a site is chosen, the build phase demands close coordination. Partners with engineering and construction expertise ensure designs meet GMP requirements, incorporate appropriate containment levels, and allow for future flexibility. They manage timelines, budgets, and vendor relationships to keep projects on track.
Early involvement of these firms often leads to better outcomes. They can provide input on constructability, modular approaches, single use technologies, and automation options that improve efficiency and reduce long term costs.
Compliance and Validation Support
Regulatory compliance remains non-negotiable. Partners familiar with FDA expectations can guide validation strategies, quality system setup, and inspection readiness. This support proves particularly valuable for companies new to US manufacturing or those working with advanced modalities.
Benefits Observed in Practice
Companies that partner effectively often report shorter project timelines, fewer costly changes during construction, and smoother transitions to operational status. These collaborations also help manage risks related to supply chain disruptions, talent shortages, and evolving regulations.
In the current environment of reshoring, partners can assist with incentive negotiations and alignment with local economic development goals. This can improve project economics and community integration.
What to Look for in a Strong Partnership
Successful collaborations rely on clear communication and aligned expectations. Seek partners who demonstrate transparency in reporting, realistic timeline projections, and a collaborative working style. References from previous clients in life sciences provide valuable insights.
Cultural fit matters too. The partner should understand the unique pressures of the industry, including the need for speed to market balanced with quality and safety standards.
Broader Context in 2026
Reshoring activity in life sciences manufacturing has created a wave of new projects across the country. Organizations see value in domestic production for supply chain security, regulatory alignment, and responsiveness to US market needs. Partnering with experienced firms helps navigate this landscape efficiently.
For companies evaluating their manufacturing strategy, these partnerships offer a way to access specialized knowledge without building massive internal infrastructure. Whether expanding existing operations or establishing first time US facilities, the right collaboration can make the difference between a smooth launch and prolonged delays.
Professionals and leaders involved in these projects benefit from starting conversations with potential partners early. Thorough due diligence and clear project scoping set the foundation for success. As the industry continues its focus on resilient and high-quality domestic manufacturing, strategic partnerships will likely play an even larger role.
The decision to build or expand manufacturing capacity represents a significant commitment. Working with the right firm helps turn that commitment into operational reality while managing the inherent complexities of life sciences facilities.
About
GForce Life Sciences is a workforce solutions provider assisting clients of all sizes in the biotech, pharma, and medical device industries. Please contact us today to start a conversation around your next project.